Journal of Virus Eradication (Dec 2017)
BCL-2 inhibitor sensitizes the latent HIV reservoir to elimination by CTLs
- S.-H. Huang,
- Y. Ren,
- A. Macedo,
- S. Patel,
- D. Chan,
- E. Horch,
- R. Truong,
- C. Bollard,
- A. Bosque,
- R.B. Jones
Affiliations
- S.-H. Huang
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- Y. Ren
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- A. Macedo
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- S. Patel
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA
- D. Chan
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- E. Horch
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- R. Truong
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- C. Bollard
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA
- A. Bosque
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- R.B. Jones
- Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA
- Journal volume & issue
-
Vol. 3
p. 32